Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2021 Jun 23;30(7):1359–1365. doi: 10.1158/1055-9965.EPI-20-1267

Table 3.

Overall and stratified prevalence ratios of stage at diagnosis comparing ACTUR with SEER among colon cases

Variables Tumor Stage Adjusted PRa (95% CI)
Stages I and II Stages III and IV
Overall
  SEER 10594 11095 1.00 (ref.)
  ACTUR 5538 5297 0.90 (0.85–0.94)
By Age
 18–39
  SEER 428 719 1.00 (ref.)
  ACTUR 208 373 1.02 (0.80-1.29)
 40–49
  SEER 862 1237 1.00 (ref.)
  ACTUR 411 643 1.00 (0.85-1.19)
 50–64
  SEER 4113 4619 1.00 (ref.)
  ACTUR 2189 2181 0.86 (0.79–0.93)
 65–74
  SEER 2987 2825 1.00 (ref.)
  ACTUR 1612 1288 0.88 (0.79–0.98)
 75 or older
  SEER 2204 1695 1.00 (ref.)
  ACTUR 1118 812 0.93 (0.82–1.06)
By Gender
 Male
  SEER 6515 6743 1.00 (ref.)
  ACTUR 3415 3206 0.87 (0.82–0.94)
 Female
  SEER 4079 4352 1.00 (ref.)
  ACTUR 2123 2091 0.93 (0.86–1.02)
By Race
 White
  SEER 8630 8537 1.00 (ref.)
  ACTUR 4518 4094 0.89 (0.84–0.95)
 Black
  SEER 1361 1810 1.00 (ref.)
  ACTUR 730 871 0.85 (0.75–0.98)
 Asian/Pacific Islander
  SEER 603 648 1.00 (ref.)
  ACTUR 290 332 1.05(0.85-1.31)
a

In the overall analysis, PR was adjusted for continuous age, sex, race, year of diagnosis, region of diagnosis, and tumor location. In stratified analysis, all variables in the overall analysis were adjusted for the variables in the overall analysis except the stratification variable itself. PR=Prevalence ratio; CI=95% confidence interval